Form 4 for PCSA Processa Pharmaceuticals, Inc.

Accepted 2021-12-07 00:00:00 ET · period of report 2021-12-03 · accession 0001567619-21-021710 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2021-12-07	2021-12-03+	PCSA	Yorke Justin W	Dir	S - Sale	$4.78	-9,700	534.4K	-2%	-$46.4K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-12-03	S	D	5,500	$4.84	538,617	I By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC	—	—	(F1) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8001 to $5.01, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
2	Common	Common Stock	2021-12-06	S	D	4,200	$4.71	534,417	I By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC	—	—	(F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.5601 to $4.80, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.